Trials / Withdrawn
WithdrawnNCT01722175
Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer
Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) Versus Portal Vein Occlusion (PVO) to Induce Liver Regeneration for Resection of Liver Tumors That Are Unresectable in One Step - a Randomized Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This randomized phase II trial compares how well associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) or portal vein occlusion (PVO) works in treating patients with liver cancer. Both treatments are types of 2-stage hepatectomies for removing liver cancer. ALPPS may be more effective than PVO in patients whose disease would traditionally be considered inoperable.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ALPPS surgery | |
| PROCEDURE | PVO surgery |
Timeline
- Primary completion
- 2016-04-01
- Completion
- 2019-01-01
- First posted
- 2012-11-06
- Last updated
- 2014-07-22
Source: ClinicalTrials.gov record NCT01722175. Inclusion in this directory is not an endorsement.